Pharmaceutical

Innovation in the pharmaceutical industry has a widespread impact that ignites competition and drives conflict in one of the most scrutinized areas of life sciences. WIT represents highly credentialed experts who know the pharmaceutical industry and can address issues regarding the research, development, and manufacturing of drugs and medications.

Pharmaceutical companies face constant challenges, including protecting intellectual property and navigating evolving government regulations. Our pharmaceutical expert team is comprised of world-class academics, industry executives, and former government regulators who were carefully selected for their knowledge, experience, and ability to communicate effectively.

Trends

FDA-Regulated Drugs and Devices

WIT represents the most qualified experts for litigation involving the science, manufacturing, and distribution of FDA-regulated drugs, chemical components, and medical devices.

Learn More

Up Next: Drug and Vaccine Development

Drug and Vaccine Development

The accelerated pace of drug and vaccine development will create many areas of dispute for pharmaceutical companies. From regulatory enforcement actions to intellectual property litigation, WIT has leading testifying experts in relevant fields.

Learn More

Up Next: FDA-Regulated Drugs and Devices

Our Experts

Our focus on the pharmaceutical industry allows us to bring together independent testifying experts under one virtual roof to address issues in complex legal disputes involving:

Clinical Trials
Trial Design, Data Analysis
Drug Safety
Diversion Prevention, Counterfeit Detection
Drug Types
Biologics, Small Molecules, OTC Drugs
Industry Landscape
Market Trends, Regulatory Impact

IP and Compliance
Patent Disputes, Regulatory Adherence
Manufacturing
cGMP, FDA Compliance
Marketing and Sales
Labeling, Pricing Strategies

Related Insights

Report

WIT Hatch-Waxman Report: Judge Michael Shipp

Our latest Hatch-Waxman report provides a comprehensive analysis of Judge Michael Shipp’s activity at the United States District Court for the District of New Jersey since his appointment in July 2012. Learn more about our findings.

Blog

Life Sciences Roundup: Top Insights from Q2 – Q3

Life sciences companies face mounting litigation over patents, products, and pricing practices. Successfully navigating these matters requires expertise from qualified experts and an expert agency focused on arising litigation trends. Check out our insights.

All Insights

What are some of our other areas of focus in Life Sciences?

Learn More